Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 117 | 0 | 101 | 0 | 103 |
| Gross Profit | 117 | N/A | 101 | N/A | 103 |
| Operating Expenses | 20,487 | 27,348 | 33,298 | 31,485 | 27,496 |
| Operating Income | -20,370 | -27,348 | -33,197 | -31,485 | -27,394 |
| Interest Expense | 0 | 0 | 0 | 178 | 282 |
| Other Income | 988 | 2,182 | 960 | 1,193 | 2,673 |
| Pre-tax Income | -19,382 | -25,166 | -32,237 | -30,470 | -25,004 |
| Net Income Continuous | -19,382 | -25,166 | -32,237 | -30,470 | -25,004 |
| Net Income | $-19,382 | $-25,166 | $-32,237 | $-30,470 | $-25,004 |
| EPS Basic Total Ops | -0.56 | -0.89 | -1.19 | -1.31 | -1.07 |
| EPS Basic Continuous Ops | -0.56 | -0.89 | -1.19 | -1.31 | -1.08 |
| EPS Diluted Total Ops | -0.56 | -0.89 | -1.19 | -1.31 | -1.07 |
| EPS Diluted Continuous Ops | -0.56 | -0.89 | -1.19 | -1.31 | -1.08 |
| EPS Diluted Before Non-Recurring Items | -0.69 | -0.89 | -1.19 | -1.31 | N/A |
| EBITDA(a) | $-19,774 | $-26,937 | $-32,839 | $-31,410 | $-23,577 |